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Abstract
Many epidemiologic, clinical, and experi-
mental findings point to sex differences in
myofascial pain in view of the fact that adult
women tend to have more myofascial problems
with respect to men. It is possible that one of
the stimuli to sensitization of fascial nocicep-
tors could come from hormonal factors such as
estrogen and relaxin, that are involved in
extracellular matrix and collagen remodeling
and thus contribute to functions of myofascial
tissue. Immunohistochemical and molecular
investigations (real-time PCR analysis) of
relaxin receptor 1 (RXFP1) and estrogen
receptor-alpha (ERα) localization were carried
out on samples of human fascia collected from
8 volunteers patients during orthopedic sur-
gery (all females, between 42 and 70 yrs, divid-
ed into pre- and post-menopausal groups), and
in fibroblasts isolated from deep fascia, to
examine both protein and RNA expression lev-
els.   We can assume that the two sex hormone
receptors analyzed are expressed in all the
human fascial districts examined and in fas-
cial fibroblasts culture cells, to a lesser degree
in the post-menopausal with respect to the
pre-menopausal women. Hormone receptor
expression was concentrated in the fibrob-
lasts, and RXFP1 was also evident in blood ves-
sels and nerves. Our results are the first
demonstrating that the fibroblasts located
within different districts of the muscular fasci-
ae express sex hormone receptors and can
help to explain the link between hormonal fac-
tors and myofascial pain. It is known, in fact,
that estrogen and relaxin play a key role in
extracellular matrix remodeling by inhibiting
fibrosis and inflammatory activities, both
important factors affecting fascial stiffness
and sensitization of fascial nociceptors.  
Introduction
It is well known that sex hormones affect
the connective tissues, above all the ligaments.
Moalli et al.1 demonstrated that type I collagen
in the arcus tendineous fasciae pelvis
decreased in post-menopausal women, possi-
bly compromising the tissue’s tensile strength
and increasing susceptibility to anterior vagi-
nal wall prolapse. Petrofsky and Lee2 demon-
strated plantar fascia elasticity changes during
the menstrual cycle, suggesting a possible role
of the sexual hormones in increasing the elas-
ticity of human connective tissue. In 1984, a
prospective study by Möller-Nielsen and
Hammar3 showed that women soccer players
were more susceptible to traumatic injuries
during premenstrual and menstrual periods
with respect to other periods of their menstru-
al cycle. Their study also disclosed that women
using contraceptive pills had a lower rate of
traumatic injuries (P<0.05) with respect non-
pill users. Following publication of that study,
many authors set out to examine how sex hor-
mones affect ligaments and cartilage. Konopka
et al.4 demonstrated, for example, that female
collegiate athletes whose serum relaxin con-
centrations were higher than 6.0 pg/mL had
more than 4 times increased risk for anterior
cruciate ligament (ACL) tears. Sex steroid
receptors have been localized in many fasciae
of the pelvic floor,5,6 suggesting that an alter-
ation in ERα in these fasciae could play an
important role in the pathophysiology of pro-
lapse and stress urinary incontinence.7
Sex receptors have also been found in the
human female ACL.8,9 Konopka et al.4 demon-
strated, for example, that relaxin-2 significant-
ly upregulated intracellular processes in
female ACL cells, but no effect was observed in
the cells of males. Relaxin increased metallo-
proteases (MMP1 and MMP3) and
decreased Alpha-smooth muscle actin (αSMA)
and Type I and III collagen expression, which
may act to alter the structural integrity of liga-
ments over time. These alterations may affect
the load bearing properties of female ACL and
contribute to non-contact ACL injuries.10
Circulating levels of relaxin and the detection
of relaxin receptor concurrent with MMPs in
multiple tissues of the trapeziometacarpal
joint have supported the hypothesis that relax-
in contributes to the cascade of joint destruc-
tion.11 In view of the fact that sex hormone
receptors have been found both in pelvic fasci-
ae and in knee ligaments, we hypothesized
that estrogen and relaxin receptors could also
be expressed in various muscular fasciae. The
current study aimed thus to investigate the
expression and the localization of relaxin
receptor 1 (RXFP1) and estrogen receptor-
alpha (ERα) in different women fascial dis-
tricts and in isolated fascial fibroblasts. The
work is a preliminary study examining, for the
first time, sex hormone receptor expression in
muscle fascia and any potential correlation
with pre- or post- menopausal periods. Its find-
ings could contribute to our understanding of
hormonal influences on myofascial properties
and to explaining the sex differences noted in
the prevalence of myofascial pain. 
Materials and Methods
This study was approved by the Institutional
Ethics Review Board (approval no.
3722/AO/16) whose ethical regulations regard-
ing research conducted on human tissues
were carefully followed. Written informed con-
sent was obtained from all of the volunteer
donors.
Samples of fascia that were a few millime-
ters wide were collected from 8 volunteers,
females patients, average age 56±10 (range
42-70), who were undergoing elective surgical
procedures at the Orthopedic Clinic of Padua
University. The samples were collected from:
the crural fascia of the leg (2 samples: one
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from a pre- and one from a post-menopausal
volunteer), the rectus sheath of the abdomen
(2 samples: one from a pre- and one from a
post-menopausal volunteer) and the fascia lata
of the thigh (4 samples: one from a pre- and
three from post-menopausal volunteers). The
samples were transported to the laboratory in
phosphate buffered saline (PBS) within a few
hours of their collection.
Each sample was divided into three sec-
tions: two were maintained in PBS and used
fresh for cell isolation and real-time PCR, the
third one was formalin-fixed for histology. The
protocols used for each sample are described
below.  Cell isolation and culture
Fascia was digested with Collagenase B
0.1% in Hank’s Balanced Salt Solution (HBSS)
overnight and fibroblast cells were isolated and
characterized by immunohistochemical stain-
ing with anti-Fibroblast Surface Protein
[1B10] antibody (1:100, Mouse monoclonal
antibodies; Abcam, Cambridge, UK), as previ-
ously described in one of our previous works.12
Cell cultures were maintained at 37°C, 95%
humidity and 5% CO2, in DMEM 1g/L glucose,
10% FBS and 1% penicillin-streptomycin
antibiotic, and used from passage 3rd to 9th. Immunocytochemistry andimmunohistochemistry 
Human fascia specimens were fixed in 10%
formalin solution overnight,  dehydrated in
graded ethanol, embedded in paraffin and cut
into 6 μm-thick sections. To detect relaxin
receptor 1 (RXFP1) and estrogen receptor-
alpha (ERα), dewaxed sections were treated
with Tris-EDTA pH 9.0 buffer for 15 min at
95°C, rinsed in water, and then washed in PBS.
Isolated cells from fascia were plated (200
cells/mm2 in 24-multiwells containing a glass
coverslip) and allowed to attach for 48 h at
37°C. Cells were then washed in PBS, fixed for
10 min with 2% paraformaldehyde in PBS pH
7.4 and then washed three times in PBS.
Afterwards, the protocol described below was
used for all the samples (tissues and cells). 
Endogen peroxidase were blocked with 1.5%
H2O2 in PBS for 10 min at room temperature.
Samples were pre-incubated with a permeabi-
lizing buffer (0.2% Tween-20 in PBS) for 60
min at room temperature and then were incu-
bated in rabbit polyclonal antibodies diluted
1:200 (cell samples) and 1:400 (tissues) for
anti-RXFP1 Receptor (Sigma-Aldrich, St. Louis,
MO, USA), and 1:100 for Estrogen Receptor
alpha (GeneTex Inc., Irvine, CA, USA). The pri-
mary antibodies were diluted in the same pre-
incubation buffer and incubated overnight at
4°C. After repeated PBS washings, samples
were incubated with the ready-to-use second-
ary antibody Advance HRP Detection System
(Dako Corp., Carpinteria, CA, USA), and
washed in PBS buffer. The reaction was then
developed with 3,3’-diaminobenzidine (Liquid
DAB + substrate Chromogen System kit,
Dako) and stopped with distilled water. 
Negative controls were similarly treated
omitting the primary antibody, confirming the
specificity of the immunostaining. Samples of
human adrenal gland sample for ERα,13 and
human skin and adrenal gland for RXFP1 were
used as positive controls as indicated in the
datasheet. Nuclei in tissue sections were
counterstained with ready-to-use hematoxylin
(Dako).
Images were acquired with the Leica DMR
microscope (Leica Microsystems, Wetzlar,
Germany; objectives 20X and 40X, Leica) and
analyzed using Image J software.Real-time PCR
Cells isolated from human fascia at the third
passage were seeded (3×104 cells/well) on a
24-well plate to examine the expression of
mRNA for ERα and RXFP1, and differences in
the fascia samples. Following 48 h of incuba-
tion in medium, the cells were harvested in
RNA lysis buffer and total RNA was extracted
with the SV Total RNA Isolation System
(Promega Corp., Madison, WI, USA) and puri-
fied. Tissue specimens were homogenized in
RNA lysis buffer, and total RNA was extracted
following the same protocol used for the cells.
To remove genomic DNA contamination, a
DNAse treatment was also carried out during
RNA extraction. The quantity and integrity of
the RNA extracted were systematically checked
using a Nanodrop 2000C spectrophotometer
(Thermo Scientific, Waltham, MA, USA), and
RNA was then transcribed into cDNA. Real-
time PCR was carried out in an I-Cycler iQ
detection system (BioRad Laboratories, Milan,
Italy), utilizing the primers listed in Table 1,
and a starting amount of 30 ng of cDNA. The
PCR program included a denaturation step at
95°C for 3 min, 40 cycles of three amplification
steps (15s 95°C - 15s 60°C - 15s 72°C) and
melting curve (60-90°C with a heating rate of
0.5°C/10 s). 
The fluorescence signal threshold was cal-
culated during the exponential phase, and the
fraction number of PCR cycles required to
reach the threshold (cycle threshold, Ct) was
determined. Ct values decreased linearly with
increasing input target quantity. All the sam-
ples were amplified in duplicate and RPS18
(Ribosomal Protein S18) expression was used
as a reference.14 The specificity of the amplifi-
cation was tested at the end of each run by
applying melting curve analysis, using the I-
Cycler sequencing Software ver. 3.0.
Despite the small size of the group of
patients analyzed (8 women), we divided the
samples into two groups (pre- and post-
menopausal) in order to compare the expres-
sion of the sex hormone receptors during two
distinct hormonal periods: pre- and post-
menopause. 
Results
The typical fascial organization of longitudi-
nally oriented collagen fibers and elongated
fibroblasts was evident in all the samples
(Figures 1 and 2), with different degrees of
cellularisation depending on the district: for
example, few fibroblasts were evident in the
crural fascia of the leg (Figure 1F), while many
and elongated cells were found in the rectus
sheath of the abdomen (Figure 1C). 
Figure 1 demonstrates the positive ERα
(panels A, D, G) and RXFP1 (panels B, E, H)
expression noted in most of the fascial fibrob-
lasts in the samples of the pre-menopausal
women, although with different degrees of
reactivity. The relaxin receptor was also evi-
dent in blood vessels (Figure 1 B,E; Figure 2G)
and nerves (Figure 2H). Those same samples
at higher magnification are shown in Figure 2.
The same expression was also evident in the
post-menopausal women (data not shown).
                                                                                                        Original Paper
Table 1. Sense and antisense sequences used as RT-PCR primers to detect RXFP1, ERα and RPS18 expression.
Sequence name                                             Acc. number                               BP                                                 Primers
RPS18 F142                                                                           NM_022551                                           111                                     5’-ATT AAG GGT GTG GGC CGA AG -3’
RPS18 R252                                                                                                                                                                                        5’-GGT GAT CAC ACG TTC CAC CT -3’
RXFP1 F1381                                                                      NM_001253727                                        132                                    5’- AGT CTC TCA GCC TAG AAG GGA-3’
RXFP1 R1512                                                                                                                                                                                     5’-TAC AGC TGC GAA CAT GTG GT -3’
ERα F1693                                                                           NM_000125.3                                          112                                         5’-ATC CAC CTG ATG GCC AAG-3’
ERα R1804                                                                                                                                                                                       5’-GCT CCA TGC CTT TGT TAC TCA -3’
[European Journal of Histochemistry 2016; 60:2710] [page 225]
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Positive tissue controls uncovered positive
cells in zona glomerulosa of the human adre-
nal gland (ERα and RXFP1) and in the spinous
layer of human epidermis (RXFP1) (data not
shown).  These results were also confirmed in
cells isolated from the same patients’ fascia
tissues described above (Figure 3), that we
characterized as fibroblasts, as we described in
one of our previous works:12 all the cells were
positive for the hormone receptors analyzed
(ERα, Figure 3 A,D,G; RXFP1, Figure 3 B,E,H),
although with different distributions and
degrees of reactivity depending on the fascial
district of origin. The cells isolated from crural
fascia (Figure 3 D-F) were, for example, small-
er and slightly less elongated with respect to
the fibroblasts of the abdominal fascia (Figure
3 A-C), and reacted showing lower positivity.
Positivity was nevertheless localized in the
cytoplasm of the cells and also in several nuclei
and nuclear membranes in all of the samples
(leg, abdomen and thigh).
The sex hormone receptors expression was
also confirmed and analyzed by means of RT-
PCR experiments that were carried out in the
cells and tissue samples of the pre- and post-
menopausal women, using the same amount
of starting cDNA. The specificity of the reac-
tions and the absence of false amplicons were
verified by monitoring if all the samples had
the same specific melting temperature for
each amplified sequence (data not shown).
The results confirmed that ERα and RXFP1
                             Original Paper
Figure 1. ERα (A,D,G) expression, RXFP1 (B,E,H) expression and H&E staining (C,F,I) of paraffin sections from samples collected
from three different districts of human fascia of three women patients: the rectus sheath of abdomen (A-C), the crural fascia of the leg
(D-F), the fascia lata of the thigh (G-I). Arrows indicate some fibroblasts (in A,D,G positive for ERα and in B,E,H positive for RXFP1);
asterisks show blood vessels, positive for RXFP1 in B,E. Scale bars: 50 μm. 
Table 2. Real time PCR Ct values in fascia tissues samples and in fascial fibroblasts in the two groups of patients: pre-menopausal and
post-menopausal women. The data represent mean ± standard deviation of at least two samples of different fascial districts in triplicate.
                                                                                     Ct fascial tissue                                                              Ct fibroblast cells
                                                                  RXFP1                  ERα               RPS18                              RXFP1                 ERα                   RPS18
Pre-menopausal women                                         32.5±1.5                     28±0.1                 18.7±2.1                                     29.8±1.6                  28.3±0.2                    15.5±0.2
Post-menopausal women                                       34.8±0.1                     32±0.4                 19.6±0.2                                     29.6±1.3                    30.1±0                       16±0.4
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were both expressed in the fibroblasts and fas-
cial tissues in both the pre- and post-
menopausal women (Table 2), although with a
lower expression compared to the housekeep-
ing gene RPS18, as indicated by the higher Ct
values. The expression of the two receptors
was lower in the post-menopausal women,
with the exception of the RXFP1 expression in
the fascial fibroblast cells: ERα had a mean Ct
of 28±0.1 in the pre-menopausal fascial tis-
sues, and of 32±0.4 in the post-menopausal
ones; the Ct of RXFP1 was 32.5±1.5 (pre-) and
34.8±0.1 (post-menopausal). The expression
values of the three genes examined showed a
lower variability in the cell samples, and there
were no significant differences in RXFP1
expressions (29.8±1.6 in the pre-menopausal
cell samples and 29.6±1.3 in post-menopausal
ones). To summarize, we can affirm that relax-
in was significantly expressed in the walls of
the blood vessels supplying fascia and also in
the fibroblasts, mainly at the cytoplasmic level,
in all of the fascial districts examined. The
estrogen receptor showed an evident expres-
sion in the fascial fibroblasts, both in the cyto-
plasm and in some nuclear membranes as well
as in some cell nuclei. 
Discussion
This is the first study demonstrating that all
fibroblasts from different districts of the mus-
cular fasciae express sex hormone receptors.
Real time RT-PCR uncovered ERα and RXFP1
expression in all analyzed women fascia, with
a lower gene expression of both investigated
receptors in the post-menopausal women with
respect to pre-menopausal ones (Table 2).
Samples of fascia were collected from three
different districts (leg, abdomen and thigh) of
8 women. To exclude variability within
patients, we averaged the Ct values resulting
from real time PCR experiments, subdividing
the results into two groups: pre- and post-
menopausal. As expected, expression resulted
lower in the latter, especially with regard to
ERα expression, according with the decrease
in estrogen hormone levels in post-
menopausal women. The current study showed
that the expression of sex hormone receptors
was prevalently localized in the fibroblast cells,
in all the samples examined. More specifically,
in the tissues not all the fibroblasts are posi-
tive, whereas the isolated and expanded cells
showed homogeneous results. This could be
explained by the fact that tissue is composed of
a pool of different cell types (fibroblasts, vascu-
lar cells, mast cells, adipocytes, etc.) with a
variability of expressions, while cell cultures
isolated from the fascia are made up of an
homogeneous type of cell.12 Relaxin receptors
are expressed not only in fibroblast cells,15,16
but also in the nerves and in blood vessels (as
shown in Figure 1 B,E and Figure 2 G,H). This
evidence could help to explain the variability of
RXFP1 expression: the expression is depend-
ent on the composition and structure of fascial
tissue and on the number of vessel cells in the
starting homogenate. Also the housekeeping
gene RPS18 in PCR experiments showed a
variability of expression between cells and fas-
cial tissue (18.7±2.1 and 19.6±0.2 in pre- and
post- menopausal fascial tissues subgroups,
respectively; 15.5±0.2 and 16±0.4 in the corre-
sponding isolated cells) that could be justified
by the different starting materials (pools of
cells and isolated fibroblasts), as indicated by
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Figure 2. ERα (A,C,E) and RXFP1 (B,D,F) expression of paraffin sections of the rectus
sheath of the abdomen (A,B), the crural fascia of the leg (C,D), and the fascia lata of the
thigh (E,F). G and H show a RXFP1 positive blood vessel and nerve, respectively. Scale
bars: 50 μm.
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the literature.17
The presence of sex hormone receptors in
fascial tissue could help to explain sex differ-
ences in the prevalence of myofascial pain.18 It
is well known that relaxin is a multifunctional
factor which contributes to collagen tissue
remodeling by inhibiting fibrosis and inflam-
matory activities19 and that a longer duration
of estrogen deficiency is associated with
increased fibrosis, as demonstrated for the
liver20 and the heart.21 In this respect, estrogen
and estrogen receptor beta (ERβ) inhibit fibro-
sis reducing TGFβ expression, connective tis-
sue growth factor production and function,
matrix metalloproteinases 2 and 9 expression
and activity, the conversion of fibroblasts to
myofibroblasts and the production of collagens
I and III. All these factors are also important to
define fascial remodeling and fascial tension.
If fascial stiffness is increased, the nociceptors
within the fascia could be sensitized causing
the underlying muscles to be stiffer.22 Lee et al.
demonstrated that women who were taking
oral contraceptives presented significantly
lower ACL elasticity with respect to their non
oral contraceptive counterparts.23 In addition,
knee flexion extension hysteresis is signifi-
cantly higher in oral contraceptive pill users
(P<0.05). Eiling et al.24 reported that musculo-
tendinous stiffness of the lower limbs of young
(between 16 and 18 years of age) female net-
ball players was significantly lower at week 3
(ovulatory phase) with respect to weeks 1 and
2 (8.7 and 4.5%, respectively).
These data are to be deepened, studying the
differences on the basis of age and gender and
presence of myofascial pain, not yet analyzed
in this work, and investigating also the expres-
sion of other receptors isoforms, such as estro-
gen receptor-beta, and the expression of other
proteins, such as progesterone receptor and G
protein-coupled estrogen receptor 1 (GPER),
that binds to and is activated by the female sex
hormone estradiol, in turn activating cellular
signaling pathways25. However, the current
work, which is the first demonstrating sex hor-
mone receptor expression in fascial fibrob-
lasts, helps to explain how hormonal factors
are linked to myofascial pain. If verified, this
new concept may lead the way to novel phar-
maceutical or mechanical approaches that
could complement existing treatments of
myofascial pain. 
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